NeuPath Health

NeuPath Health EBITDA Margin

The EBITDA Margin of NeuPath Health (NPTH.V) as of Nov 12, 2026 is 2.34 %. In the previous year, EBITDA Margin was 5.09 % — a change of -54.13% (lower).

EBITDA Margin

2.34 %

YoY

-54.13%

Last updated:

EBITDA Margin of NeuPath Health is 2025 2.34 % . EBITDA Margin of NeuPath Health was 2024 5.09 % . It decreases by -54.13% lower compared to the previous year.

The NeuPath Health EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2019
3.61 CAD
Jan 1, 2020
3.52 CAD
Jan 1, 2021
1.94 CAD
Jan 1, 2022
2.25 CAD
Jan 1, 2024
5.09 CAD
Jan 1, 2025
2.34 CAD
The NeuPath Health EBITDA Margin history
YEAREBITDA MarginYoY
2.34 %-54.13%
5.09 %+126.34%
2.25 %+16.18%
1.94 %-45.08%
3.52 %-2.27%
3.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuPath Health stock

EBITDA Margin of NeuPath Health is 2.34 % in 2025.

EBITDA Margin of NeuPath Health changed from 5.09 % to 2.34 %, representing a -54.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's NeuPath Health with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — NeuPath Health

All Key Metrics — NeuPath Health